bile duct cancer

Mayo Clinic Cancer Center researchers identify promising drug to treat gastrointestinal cancers

Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.

Treating early stage bile duct cancer with chemoradiation, liver transplant

Chemoradiation followed by liver transplant is being used more widely to treat perihilar cholangiocarcinoma, the most common form of bile duct cancer.

NCI funds spore for liver and bile duct cancer research

A team of researchers from the Mayo Clinic Cancer Center has been awarded a five-year, $11.5-million Specialized Program of Research Excellence (SPORE) grant in hepatobiliary[...]